Cargando…
维莫非尼治疗BRAF(V600E)突变型Erdheim-Chester病的疗效与安全性分析
OBJECTIVE: To evaluate the safety and efficacy of vemurafenib in the treatment of BRAF(V600E)-mutated Erdheim-Chester disease (ECD). METHODS: We retrospectively analyzed the clinical data, response rate, adverse events and survival of 12 patients with ECD treated with vemurafenib from March 2015 to...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607034/ https://www.ncbi.nlm.nih.gov/pubmed/34753230 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.09.007 |